NexgenRx Inc
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. The company offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. It also provides ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquarte… Read more
Market Cap & Net Worth: NexgenRx Inc (NEGXF)
NexgenRx Inc (PINK:NEGXF) has a market capitalization of $13.87 Million ($13.87 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #29173 globally and #9679 in its home market, demonstrating a -2.50% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NexgenRx Inc's stock price $0.20 by its total outstanding shares 71117104 (71.12 Million).
NexgenRx Inc Market Cap History: 2017 to 2025
NexgenRx Inc's market capitalization history from 2017 to 2025. Data shows growth from $12.29 Million to $13.87 Million (0.00% CAGR).
NexgenRx Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NexgenRx Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.86x
NexgenRx Inc's market cap is 0.86 times its annual revenue
1.54x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
23.14x
NexgenRx Inc's market cap is 23.14 times its annual earnings
252.98x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $12.29 Million | $5.72 Million | -$635.06K | 2.15x | N/A |
| 2018 | $14.42 Million | $6.93 Million | -$694.65K | 2.08x | N/A |
| 2020 | $12.47 Million | $10.42 Million | $2.12 Million | 1.20x | 5.88x |
| 2021 | $22.26 Million | $11.88 Million | $4.05 Million | 1.87x | 5.50x |
| 2022 | $13.82 Million | $12.46 Million | -$22.20K | 1.11x | N/A |
| 2023 | $13.51 Million | $13.85 Million | -$331.97K | 0.98x | N/A |
| 2024 | $14.22 Million | $16.48 Million | $614.57K | 0.86x | 23.14x |
Competitor Companies of NEGXF by Market Capitalization
Companies near NexgenRx Inc in the global market cap rankings as of March 19, 2026.
Key companies related to NexgenRx Inc by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #724 globally with a market cap of $28.17 Billion USD.
- BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ:BTSGU): Ranked #989 globally with a market cap of $19.86 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2240 globally with a market cap of $6.77 Billion USD.
- HealthEquity Inc (NASDAQ:HQY): Ranked #2273 globally with a market cap of $6.65 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #724 | Veeva Systems Inc Class A | NYSE:VEEV | $28.17 Billion | $186.70 |
| #989 | BrightSpring Health Services, Inc. Tangible Equity Unit | NASDAQ:BTSGU | $19.86 Billion | $139.72 |
| #2240 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $6.77 Billion | $42.10 |
| #2273 | HealthEquity Inc | NASDAQ:HQY | $6.65 Billion | $79.40 |
NexgenRx Inc Historical Marketcap From 2017 to 2025
Between 2017 and today, NexgenRx Inc's market cap moved from $12.29 Million to $ 13.87 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $13.87 Million | -2.50% |
| 2024 | $14.22 Million | +5.32% |
| 2023 | $13.51 Million | -2.26% |
| 2022 | $13.82 Million | -37.92% |
| 2021 | $22.26 Million | +78.55% |
| 2020 | $12.47 Million | -13.56% |
| 2018 | $14.42 Million | +17.36% |
| 2017 | $12.29 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of NexgenRx Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $13.87 Million USD |
| MoneyControl | $13.87 Million USD |
| MarketWatch | $13.87 Million USD |
| marketcap.company | $13.87 Million USD |
| Reuters | $13.87 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.